Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011

…, T Chiba, M Mishima, T Hibi, H Tsubouchi… - Modern …, 2012 - Taylor & Francis
IgG4-related disease (IgG4-RD) is a novel clinical disease entity characterized by elevated
serum IgG4 concentration and tumefaction or tissue infiltration by IgG4+ plasma cells. …

Evidence for the identity of human scatter factor and human hepatocyte growth factor.

…, H Rieder, C Fonatsch, H Tsubouchi… - Proceedings of the …, 1991 - National Acad Sciences
Scatter factor (SF), a secretory protein of fibroblasts, dissociates and increases the motility of
epithelial cells and may be involved in cell migration processes during embryogenesis and …

Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor

K Miyazawa, H Tsubouchi, D Naka, K Takahashi… - Biochemical and …, 1989 - Elsevier
Amino acid sequences of four peptide fragments of human hepatocyte growth factor purified
from the plasma of patients with fulminant hepatic failure were determined. Based on the …

Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma

…, H Kumada, N Hayashi, S Kaneko, H Tsubouchi… - European journal of …, 2011 - Elsevier
BACKGROUND: In Japan and South Korea, transarterial chemoembolisation (TACE) is an
important locoregional treatment for patients with unresectable hepatocellular carcinoma (…

Clinical diagnostic criteria of IgG4-related sclerosing cholangitis 2012

H Ohara, K Okazaki, H Tsubouchi, K Inui… - Journal of hepato-biliary …, 2012 - Springer
Background IgG4-sclerosing cholangitis (IgG4-SC) patients have an increased level of serum
IgG4, dense infiltration of IgG4-positive plasma cells with extensive fibrosis in the bile duct …

[HTML][HTML] Evidence-based clinical practice guidelines for liver cirrhosis 2015

…, M Seike, S Nagoshi, M Segawa, H Tsubouchi… - Journal of …, 2016 - Springer
The Japanese Society of Gastroenterology revised the evidence-based clinical practice
guidelines for liver cirrhosis in 2015. Eighty-three clinical questions were selected, and a …

[HTML][HTML] Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

…, I Sakaida, M Nakamuta, T Mizuta, H Tsubouchi… - Journal of …, 2015 - Springer
Nonalcoholic fatty liver disease (NAFLD) is currently the most common cause of chronic
liver disease in industrialized countries worldwide, and has become a serious public health …

[PDF][PDF] Genome-wide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population

…, Y Maehara, S Uemoto, N Kokudo, H Tsubouchi… - The American Journal of …, 2012 - cell.com
For the identification of susceptibility loci for primary biliary cirrhosis (PBC), a genome-wide
association study (GWAS) was performed in 963 Japanese individuals (487 PBC cases and …

BCAA-enriched snack improves nutritional state of cirrhosis

…, H Okuda, M Onji, H Kanazawa, H Tsubouchi… - Nutrition, 2007 - Elsevier
OBJECTIVE: A late evening snack improves the catabolic state in patients with advanced
liver cirrhosis. We tested whether long-term (3 mo) late evening snacking that included a …

Telaprevir with peginterferon and ribavirin for treatment-naive patients chronically infected with HCV of genotype 1 in Japan

…, J Toyota, T Okanoue, K Chayama, H Tsubouchi… - Journal of …, 2012 - Elsevier
BACKGROUND & AIMS: To evaluate the efficacy and safety of telaprevir in combination
with peginterferon-α2b (PEG-IFN) and ribavirin (RBV) in patients with chronic hepatitis C. …